Contineum Therapeutics, Inc. (CTNM) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading CTNM…

Contineum Therapeutics, Inc. (CTNM) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Contineum Therapeutics, Inc.

CTNM · CIK 1855175

4 · Feb 13, 2026 · Stengone Carmine N. sold 400 shares at $16.00/share ($6,400); exercised options for 400 shares

4

Stengone Carmine N. sold 400 shares at $16.00/share ($6,400); exercised options for 400 shares

Filed: Feb 13, 2026
Period: Feb 11, 2026
Accession: 0001437749-26-004126
Filer: Contineum Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X05/rdgdoc.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4rdgdoc.xml
Open SEC.gov